Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.
2.

Recent advances in in vivo screening for antiarrhythmic drugs.

MacRae CA.

Expert Opin Drug Discov. 2013 Feb;8(2):131-41. doi: 10.1517/17460441.2013.743990. Epub 2013 Jan 12. Review.

PMID:
23311759
3.

Recent progress in the use of zebrafish for novel cardiac drug discovery.

Keßler M, Rottbauer W, Just S.

Expert Opin Drug Discov. 2015;10(11):1231-41. doi: 10.1517/17460441.2015.1078788. Epub 2015 Aug 18. Review.

PMID:
26294375
4.

Functional genomics in zebrafish as a tool to identify novel antiarrhythmic targets.

Pott A, Rottbauer W, Just S.

Curr Med Chem. 2014;21(11):1320-9. Review.

PMID:
24372224
5.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
6.

Zebrafish genetic models for arrhythmia.

Milan DJ, Macrae CA.

Prog Biophys Mol Biol. 2008 Oct-Nov;98(2-3):301-8. doi: 10.1016/j.pbiomolbio.2009.01.011. Epub 2009 Jan 31. Review.

7.

The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation.

Yoganantharjah P, Gibert Y.

Curr Top Med Chem. 2017;17(18):2041-2055. doi: 10.2174/1568026617666170130112109. Review.

PMID:
28137236
8.

Platforms for the identification of GPCR targets, and of orthosteric and allosteric modulators.

Franco R, Canela EI, Casado V, Ferre S.

Expert Opin Drug Discov. 2010 Apr;5(4):391-403. doi: 10.1517/17460441003653163.

PMID:
22823089
9.

Computational systems approach for drug target discovery.

Chandra N.

Expert Opin Drug Discov. 2009 Dec;4(12):1221-36. doi: 10.1517/17460440903380422.

PMID:
23480463
10.

Systems biology visualization tools for drug target discovery.

Huan T, Wu X, Chen JY.

Expert Opin Drug Discov. 2010 May;5(5):425-39. doi: 10.1517/17460441003725102. Epub 2010 Apr 19.

PMID:
22823128
11.

Cell-based apoptosis assays in oncology drug discovery.

Drewe J, Cai SX.

Expert Opin Drug Discov. 2010 Jun;5(6):583-96. doi: 10.1517/17460441.2010.486829.

PMID:
22823169
12.

[Aiming for zero blindness].

Nakazawa T.

Nippon Ganka Gakkai Zasshi. 2015 Mar;119(3):168-93; discussion 194. Review. Japanese.

PMID:
25854109
13.

Zebrafish: from disease modeling to drug discovery.

Rubinstein AL.

Curr Opin Drug Discov Devel. 2003 Mar;6(2):218-23.

PMID:
12669457
14.

Zebrafish as a genetic model in pre-clinical drug testing and screening.

Gibert Y, Trengove MC, Ward AC.

Curr Med Chem. 2013;20(19):2458-66. Review.

PMID:
23521675
15.

Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery.

Barros TP, Alderton WK, Reynolds HM, Roach AG, Berghmans S.

Br J Pharmacol. 2008 Aug;154(7):1400-13. doi: 10.1038/bjp.2008.249. Epub 2008 Jun 16. Review.

16.

Significance of the zebrafish model in the discovery of bioactive molecules from nature.

Mandrekar N, Thakur NL.

Biotechnol Lett. 2009 Feb;31(2):171-9. doi: 10.1007/s10529-008-9868-1. Epub 2008 Oct 19. Review.

PMID:
18931972
17.

Induced pluripotent stem cells as cardiac arrhythmic in vitro models and the impact for drug discovery.

Sarić T, Halbach M, Khalil M, Er F.

Expert Opin Drug Discov. 2014 Jan;9(1):55-76. doi: 10.1517/17460441.2014.863275. Epub 2013 Dec 3. Review.

PMID:
24294840
18.

Using zebrafish to unravel the genetics of complex brain disorders.

Gerlai R.

Curr Top Behav Neurosci. 2012;12:3-24. doi: 10.1007/7854_2011_180. Review.

PMID:
22250005
19.

How can high-throughput screening deliver drugs to treat atherosclerosis?

Yang Y, Wang L, Si S, Hong B.

Expert Opin Drug Discov. 2010 Dec;5(12):1175-88. doi: 10.1517/17460441.2010.529896.

PMID:
22822720
20.

Gene expression profiling to identify druggable targets in prion diseases.

Benetti F, Gasperini L, Zampieri M, Legname G.

Expert Opin Drug Discov. 2010 Feb;5(2):177-202. doi: 10.1517/17460440903544449. Epub 2010 Jan 9.

PMID:
22822917

Supplemental Content

Support Center